Phillips, Andrew N
Cambiano, Valentina
Nakagawa, Fumiyo
Revill, Paul
Jordan, Michael R
Hallett, Timothy B
Doherty, Meg
De Luca, Andrea
Lundgren, Jens D
Mhangara, Mutsa
Apollo, Tsitsi
Mellors, John
Nichols, Brooke
Parikh, Urvi
Pillay, Deenan
Rinke de Wit, Tobias
Sigaloff, Kim
Havlir, Diane
Kuritzkes, Daniel R
Pozniak, Anton
van de Vijver, David
Vitoria, Marco
Wainberg, Mark A
Raizes, Elliot
Bertagnolio, Silvia
Phillips, Andrew N
Cambiano, Valentina
Nakagawa, Fumiyo
Revill, Paul
Jordan, Michael R
Hallett, Timothy B
Doherty, Meg
De Luca, Andrea
Lundgren, Jens D
Mhangara, Mutsa
Apollo, Tsitsi
Mellors, John
Nichols, Brooke
Parikh, Urvi
Pillay, Deenan
Rinke de Wit, Tobias
Sigaloff, Kim
Havlir, Diane
Kuritzkes, Daniel R
Pozniak, Anton
van de Vijver, David
Vitoria, Marco
Wainberg, Mark A
Raizes, Elliot
Bertagnolio, Silvia
Funding for this research was provided by:
United States Agency for International Development
This article is maintained by: Elsevier
Article Title: Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
Journal Title: The Lancet HIV
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S2352-3018(17)30190-X
CrossRef DOI link to the associated document: https://doi.org/10.1016/S2352-3018(17)30207-2
Content Type: article
Copyright: